[1] 曲范杰,黄杰.二膦酸盐治疗恶性肿瘤骨转移的疗效分析[J].中华肿瘤学,2009,29(2): 118-119.
[2] 朱广迎.放射肿瘤学[M].北京:北京科学技术文献出版社,2009: 76-80.
[3] 勇昆,牛晓辉.骨肉瘤诊断、治疗、随访的ESMO临床指南[J].中国骨肿瘤骨病,2010,9(2):110-111.
[4] 刘琦,李晓阳,肖涛.骨肉瘤优化新辅助化疗方案临床疗效观察[J]中国医师杂志,2014,16(5):634-637
[5] Canon JR, Roudier M, Bryant R, et al. Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis. Clin Exp Metastasis.2010; 89(3):411-417.
[6] Granchi D, Scarso A, Bianchini G,et al.Low toxicity and unprecedented anti-osteoclast activity of a simple sulfur-containing gem-bisphosphonate: a comparative study.Eur J Med Chem. 2013;65:448-455.
[7] DE Iuliis F, Taglieri L, Amoroso L,et al.Prevention of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates.Anticancer Res. 2014; 34(5): 2477-2480.
[8] Iguchi K,Nakano T,Usui S,et al.Incadronate inhibits aminopeptidase N expression in prostatic PC-3 cells. Cancer Lett,2006;237(2):223-233.
[9] Tassone P,Tagliaferri P,Viscomi C,et al.Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro. Br J Cancer.2011; 88(12): 1971-1978.
[10] Baulch BC,Molloy TJ,Yeh SL,et al.Inhibitors of the mevalonate pathway as potential therapeutic agents in multiple myeloma. Leuk Res.2010;31(3):341-352.
[11] Chang Z, Xing J, Yu X, et al. Curcumin induces osteosarcoma MG63 cells apoptosis via ROS/Cyto-C/Caspase-3 pathway. Tumour Biol.2014;35(1):753-758.
[12] Lauricella M, D'Anneo A, Giuliano M, et al.Induction of apoptosis in human osteosarcoma Saos-2 cells by the proteasome inhibitor MG132 and the protective effect of pRb. Cell Death Differ. 2003;10(8):930-932.
[13] Jin S, Pang RP, Shen JN, et al. Grifolin induces apoptosis via inhibition of PI3K/AKT signalling pathway in human osteosarcoma cells. Apoptosis. 2007;12(7):1317-1326.
[14] Ito Y, Pandey P, Sporn MB,et al. The novel triterpenoid CDDO induces apoptosis and differentiation of human osteosarcoma cells by a caspase-8 dependent mechanism. Mol Pharmacol. 2001;59(5):1094-1099.
[15] Zhang Y, Bhavnani BR.Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release. BMC Neurosci. 2005;6:13.
[16] Sangha R, Lara PN Jr, Adjei AA, et al. Cooperative group research endeavors in small-cell lung cancer: current and future directions. Clin Lung Cancer. 2009;10(5):322-330.
[17] Chen J, Ye L, Zhang L, et al. The molecular impact of pigment epithelium-derived factor, PEDF, on lung cancer cells and the clinical significance. Int J Oncol. 2009;35(1):159-166.
[18] Jesien-Lewandowicz E, Spych M, Fijuth J,et al. Solitary brain metastasis of an occult and stable small-cell lung cancer in a schizophrenic patient: a 3-year control. Lung Cancer. 2010; 69(2):245-246.
[19] Karczmarek-Borowska B, Zielińska K, Buka?a A,et al. Hyponatremia in the course of small cell lung cancer-a case report.organ Polskiego Towarzystwa Lekarskiego, 2014;37 (217):2852-2856.
[20] Hann CL, Rudin CM. Management of small-cell lung cancer: incremental changes but hope for the future. Oncology (Williston Park). 2008;22(13):1486-1492.
[21] Xenidis N, Kotsakis A, Kalykaki A,et al.Etoposide plus cisplatin followed by concurrent chemo-radiotherapy and irinotecan plus cisplatin for patients with limited-stage small cell lung cancer: A multicenter phase II study. Lung Cancer. 2010 ;68(3):1145-1148.
[22] Usuda J, Ichinose S, Ishizumi T, et al. Klotho predicts good clinical outcome in patients with limited-disease small cell lung cancer who received surgery. Lung Cancer. 2011;74(2): 332-337.
[23] Li Y, Xu J, Mao L, et al.Allogeneic mesenchymal stem cell therapy for bisphosphonate•related jaw osteonecrosis in Swine.Stem Cells Dev.2013;22(14):2047-2056.
[24] Chen QY, zheng Y, Jiao DM, et al. Curumin in hibits lung cancer cell migration and invasion through racl dependent signaling pathway.Nutrbiochem 2014;25(2):177-185.
[25] Busch AM, Johnson KC, Stan RN, et al. Evidence for tankyrases as antine tineoplastic targets in lung cancer.BMC Cancer.2013;13:211.
[26] Lau T, Chan E, Callow M, et al. A novel tankyrase small molecule inhibitor suppresses APC mutation driven colorectal tumor growth.Cancer Res. 2013;73(10):3132-3144
[27] Foerster R, Eisele C, Bruckner T, et al. Bone density as a marker for local response to radiotherapy of spinal bone metastases in women with breast cancer: a retrospective analysis. Radiat Oncol.2015;10:62.
[28] Khorasani MS, Diko S, Hsia AW, .et al. Christiansen Effect of alendronate on post-traumatic osteoarthritis induced by anterior cruciate ligament rupture in mice. Arthritis Res Ther. 2015;17:30
[29] Reynolds K,Viswanathan HN,Muntner P,et al.O'Malley Quality of life research,Validation of the Osteoporosis- Specific Morisky Medication Adherence Scale in long-term users of bisphosphonates.Qual Life Res.2014;23(7): 2109-2120.
[30] Lubwama R, Nguyen A, Modi A, et al.Prevalence of renal impairment among osteoporotic women in the USA, NHANES 2005-2008: is treatment with bisphosphonates an option? Osteoporos Int. 2014;25(5):1607-1615. |